Blueprint Medicines announces pricing of public offering of common stock
Blueprint Medicines announced pricing of an underwritten public offering of 5,000,000 shares of its common stock at a public offering price of $25.00 per share. In addition, Blueprint granted underwriters a 30-day option to purchase up to an additional 750,000 shares of its common stock. December 07, 2016